Publications
126
Citations
2,679
Est. group size
~14
Recurring co-author estimate
Active years
48
Publishing since 1979
Joseph P. McElroy's work centers on cancer biology, particularly glioblastoma (a type of brain tumor) and other cancers, examining molecular mechanisms of disease and potential drug combination therapies. His research also touches on medical imaging analysis methods and epigenetic changes (chemical modifications to DNA that affect gene activity) linked to disease. Much of his role in these studies likely involves biostatistical or data analysis support given the collaborative, multi-author nature of the publications.
Publication output peaked around 2018 and has generally declined since, settling at a lower and more modest annual rate in recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- An Introduction to Quantum Imaging and Hologram
River Publishers eBooks · 2023
- The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells
Journal of Neuro-Oncology · 2018
- EXTH-75. THE AURORA KINASE A INHIBITOR ALISERTIB IS SYNERGISTIC WITH IRINOTECAN AND CARBOPLATIN AGAINST GLIOBLASTOMA CELLS
Neuro-Oncology · 2018
- Neuro-Oncology×27
- Cancer Research×11
- Journal of Clinical Oncology×7
- Oncotarget×4
- International Journal of Radiation Oncology*Biology*Physics×4
- Arnab Chakravarti
Medicine · The Ohio State University
- Yanwei Liu
Medicine · The Ohio State University
- J. McElroy
Medicine · The Ohio State University
- Arnab Chakravarti
Medicine · The Ohio State University
- Kathryn Nevel
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile